April 2009 news about us

Articles that mention MVI

What's the best way to fight malaria?
April 27, 2009 – Nine out ten of malaria deaths occur in Africa - that’s nearly 1 million fatalities a year. The World Health Organisation estimates the financial loss to Africa because of malaria at 12 billion dollars a year.
Reuters "Africa Blog"

Tests of malaria vaccine positive
April 28, 2009 – Clinical trial of a malaria vaccine, RTSS, on children at Kintampo and Agogo has showed that the vaccine is safe for use by children, Dr Kwaku Poku Asante, a research scientist, has told journalists in Accra.
Ghanaian Times

Soccer pro survives malaria, now helps others
April 27, 2009 – Saana Nyassi considers himself lucky. He is fortunate not just because he has a natural talent for soccer and the dedication to rise through the ranks in his native Gambia and eventually go to the United States to play for the Seattle Sounders. Before leaving the tiny West African nation for America, Nyassi contracted malaria.
CNN

Tanzania lined-up for third phase of malaria vaccine
April 27, 2009 – Tanzania is one of the eight African countries lined-up for the third phase Malaria Vaccine Programme trials scheduled to kick-off in July, this year.
The Guardian (Tanzania)

World Malaria Day
April 25, 2009 – CNN's Rosemary Church looks at the global effort to fight malaria.
CNN

A vaccine against malaria: a substantial step forward
April 25, 2009 – Two recent studies by Philip Bejon and Salim Abdulla and their respective colleagues, represent an important step towards the development of a malaria vaccine that shows great promise for being deployable in malaria-control programmes.
The Lancet

Putting malaria vaccine to the test
April 25, 2009 – LAMBERENE, Gabon – On a sweltering Sunday morning in a tiny village outside this town, Chancia Amoko, 23, sits in an armchair under a palm tree and explains why she has volunteered her infant daughter to be part of one of the largest clinical drug trials ever conducted in Africa.
Toronto Star

Glaxo to start final-stage malaria vaccine trial
April 24, 2009 – GENEVA/LONDON (Reuters) - GlaxoSmithKline Plc is about to start final-stage clinical trials of the world's most advanced malaria vaccine, which could reach the market within three years, the drugmaker said on Friday. If successful, Glaxo believes its Mosquirix vaccine has the potential to save hundreds of thousands of deaths and prevent tens of millions of cases of malaria in Africa.
Reuters

Goal of eliminating malaria in sight
April 24, 2009 – GENEVA, April 24 (Reuters) - Fresh efforts and funding to tackle malaria in recent years have brought the goal of eradicating the deadly disease within sight, health experts said on Friday.
Reuters

HEALTH: Final push to control malaria by 2015
April 24, 2009 – About one million people die every year from malaria, including a child every 30 seconds. Half a billion people are infected annually.
Inter Press Service

PATH initiating phase-1 trial for new malaria vaccine candidate
April 24, 2009 – Officials from the PATH Malaria Vaccine Initiative announced yesterday that, in partnership with Sanaria Inc., they will begin recruiting participants for a phase-1 trial of a new malaria vaccine. The FDA recently approved the vaccine candidate for phase-1 trials in humans.
Infectious Diseases in Children

Moving disease to the next level
April 23, 2009 – Kenya has seen Malaria deaths drop from 32,000 to 25,000 annually in the recent past. But this still means that we are losing 25,000 potential heroes who might make a difference globally, just like US President Barack Obama did.
Daily Nation (Kenya)

Treatments: Vaccines face first big test
April 23, 2009 – The first big clinical trial of a malaria vaccine is about to start in Africa. After more than 20 years in research and development, the RTS,S vaccine will be given to some 14,000 babies and children in seven countries over the next two or three years.
Financial Times

World’s best chance to tackle killer
April 23, 2009 – As politicians, personalities and physicians gather at events around the world linked to World Malaria Day tomorrow, they have good reason to celebrate – but just as many reasons to pause for contemplation as they prepare for the considerable challenges ahead.
Financial Times

A new push to combat malaria
April 23, 2009 – With a recent sharp jump in funding and advocacy, World Malaria Day deserves more attention than most such contrived anniversaries. The rising excitement also needs a little tempering.
Financial Times

Funding: Credit crisis spurs fiscal innovation
April 23, 2009 – Despite the pressure of the economic downturn on banks and donors, Kate Campana has been pursuing work on a mechanism to overcome a frustratingly rudimentary barrier to the rapid distribution of bed nets to prevent malaria.
Financial Times

Sanaria works on new prototype for malaria vaccine
April 23, 2009 – Washington, D.C (AHN) - Maryland-based Sanaria Inc. has entered phase 1 of many trials to come that may yield a cost-effective treatment for malaria."Initiation of this trial expands the spectrum of malaria vaccines in clinical development today," said Dr. Christian Loucq, Director of Malaria Vaccine Initiative said in a press release.
All Headline News

Volunteers? PATH-supported malaria vaccine begins human testing
April 23, 2009 – The malaria eradication efforts of Seattle-based PATH are moving ahead today with the first human trials of one of its vaccine candidates -- a "whole parasite" vaccine made by Sanaria.
Seattle Times

Sanaria to begin human trials of malaria vaccine
April 23, 2009 – A Rockville company plans to begin the first human clinical trials of a malaria vaccine that uses a weakened version of the entire malaria parasite, instead of just pieces of it, to help shield victims from the disease.
Washington Business Journal

Human trials begin in malaria vaccine candidate
April 23, 2009 – Sanaria, Inc. and the PATH Malaria Vaccine Initiative announced this morning that their potential vaccine for malaria ready to start human trials as early as this May.
Foreign Policy's "Passport" Blog

Rockville firm's malaria vaccine moves to trials
April 23, 2009 – A Washington area biotech said today that it won approval to test its malaria vaccine in healthy adults.
Washington Post's "WashBiz" Blog

Trial debut for malaria vaccine from mosquito spit
April 23, 2009 – A unique malaria vaccine extracted from the saliva of infected mosquitoes this week received clearance from the US Food and Drug Administration to be tested in people.
New Scientist

Maryland company starts trial of malaria vaccine
April 23, 2009 – WASHINGTON (Reuters) - A small Maryland-based company backed by nonprofit and government funds said on Thursday it had won permission to start testing its malaria vaccine in people.
Reuters

Sanaria starts adult trial of malaria vax
April 23, 2009 – Rockville, MD-based Sanaria has launched a Phase I trial of its malaria vaccine candidate in adults. Working with the backing of the PATH Malaria Vaccine Initiative, Sanaria is recruiting 104 volunteers to take the vaccine, which uses a weakened form of the whole parasite taken from irradiated mosquitoes rather than portions of the parasite.
FierceVaccines

Bioengineered bugs could lead to malaria vaccine
April 23, 2009 – For most Americans, mosquitoes are pests whose bites leave behind itchy bumps. But in other parts of the world, mosquitoes carry a disease called malaria that kills more than a million people each year. Mosquitoes, especially those in Sub-Saharan Africa, may transmit malaria to humans.
CNN.com

Counting malaria out
April 23, 2009 – I have spent my entire working life trying to combat tropical disease. But I was aghast when, in October 2007, Bill Gates called for the eradication of malaria.
New Statesman (UK)

Burkina Faso: Lutte contre le paludisme - Un nouveau vaccin expérimenté à Nanoro
April 23, 2009 – L'unité de recherche clinique de Nanoro, à 85 km de Ouagadougou, destiné principalement à expérimenter le candidat vaccin contre le paludisme, RTS,S, a été officiellement inauguré le mardi 21 avril 2009 par le ministre de la Santé, Seydou Bouda, sous le parrainage de Mme Priscille Zongo, épouse du Premier ministre burkinabè.
Sidwaya Quotidien (Burkina Faso)

Gabon: Vaccin RTS, S : "Les travaux de recherche ont obtenu l’avis favorable du CNER", Docteur Pierre Blaise Matsiégui
April 23, 2009 – Libreville – Le docteur Pierre Blaise Matsiégui, chercheur à l’unité de recherche médicale de l’hôpital Albert Schweitzer à Lambaréné au centre du Gabon, a déclaré au sujet du vaccin RTS, S que " les travaux de recherche ont obtenu l’avis favorable du Comité national d’éthique pour la recherche (CNER) ".
GaboNews (Gabon)

Gambia: Count malaria out
April 22, 2009 – We are once again warming up to the commemoration of World Malaria Day. Such occasions are more than mere celebrations; they should be utilized in the most efficient way to develop sustainable measures that can finally roll back malaria.
Daily Observer (Gambia)

Gabon: Le réseau des journalistes africains pour la lutte contre le paludisme visite l’URM de Lambaréné
April 22, 2009 – L’Unité de recherche médicale (URM) du Gabon, basée à Lambaréné (Centre) dans l’enceinte de l’hôpital Albert Schweitzer, a reçu, il y a trois jours des membres de l’antenne locale du réseau des journalistes africains pour la lutte contre le paludisme.
Bongo Doit Partir (Gabon)

Counting malaria out
April 13, 2009 – Malaria is a preventable and treatable disease, but as MEPs will hear at a special working lunch next week in Strasbourg, EU leadership and decisive action are needed to tackle the number one killer disease in Africa.
Parliament Magazine

Knockout blow
April 13, 2009 – The head of a small Indian manufacturing plant picks up the phone and calls the director of a not-for-profit product development partnership in Denmark.
Parliament Magazine